Warsaw, INA manufacturer of an artificial knee replacement system that has come under fire for allegedly poor performance is striking back at law firms who are alleged to have undertaken advertising campaigns on television and the Internet presumably to recruit plaintiffs. The Zimmer NexGen CR-Flex Porous Femoral component is alleged to have a high failure rate.
The CR-Flex, as noted above, was linked to a high failure rate according to a study published last year in the American Academy of Orthopedic Surgeons. Some in the medical community are said to be calling for a Zimmer knee replacement recall of the Zimmer NexGen CR-Flex Porous Femoral component.
Needless to say, lawsuits over failed or failure-prone medical devices are common after patients discover that the kind of rejuvenated movement promised by manufacturers of medical devices fails to materialize. Many patients of knee replacement systems by various manufacturers have been seen to trade reasonable expectation with constant pain and restricted movement.
Legal firms, in an effort to educate and inform patients outfitted with problematic medical devices about their options, will attempt to reach patients where they are—at the computer desk or sitting in front of the couch watching television.
According to the February 18 edition of the Fort Wayne Journal Gazette, Zimmer has filed lawsuits against various legal firms alleging defamation, wrongful interference with business relationships and trademark infringement.
It was not specified by the Journal Gazette if the Zimmer NexGen Knee Replacement system identified in the advertising was the Zimmer NexGen CR-Flex Porous Femoral component. Documents were filed last month at US District Court for the Northern District of Indiana.
Zimmer knee implants are but one option for an increasingly aging population coming into a need for artificial joints in an effort to enhance and prolong their mobility. The imposing Baby Boom Generation is starting to reach retirement age—and as the remainder of that demographic moves into retirement and moves through the age at which artificial joints are needed, a groundswell of increased activity is anticipated.
Manufacturers of medical devices, in the rush to bring new products to market, can take advantage of a loophole in regulations observed by the US Food and Drug Administration (FDA) that save manufacturers from the requirement to undertake clinical trials if the new device is substantially similar to existing devices.
The manufacturer of Zimmer NexGen was reported to have eliminated an unspecified number of jobs at its orthopedics operation last month on the heels of fourth-quarter earnings coming in at 78 percent below Q4 results of the previous year.
If you or a loved one have suffered losses in this case, please click the link below and your complaint will be sent to a defective products lawyer who may evaluate your Zimmer NexGen claim at no cost or obligation.